A retrospective analysis of cross‐reacting cetuximab IgE antibody and its association with severe infusion reactions-Reference-Cited by-同舟云学术

A retrospective analysis of cross‐reacting cetuximab IgE antibody and its association with severe infusion reactions

Published:2014-10-09 Issue:1 Volume:4 Page:36-42
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Maier Sabine¹,Chung Christine H.²,Morse Michael³,Platts‐Mills Thomas⁴,Townes Leigh¹,Mukhopadhyay Pralay⁵,Bhagavatheeswaran Prabhu⁵,Racenberg Jan⁵,Trifan Ovidiu C.⁵

Affiliation:

1. Bristol‐Myers Squibb Company Lawrenceville New Jersey

2. Johns Hopkins University Baltimore Maryland

3. Duke University Medical Center Durham North Carolina

4. University of Virginia Charlottesville Virginia

5. Bristol‐Myers Squibb Company Wallingford Connecticut

Funder

Bristol-Myers Squibb

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.333

Reference16 articles.

1. Herceptin (trastuzumab) [package insert].2014.Genentech Inc South San Francisco CA.

2. Rituxan (rituximab) [package insert].2013.Genentech Inc South San Francisco CA.

3. Avastin (bevacizumab) [package insert].2013.Genentech Inc South San Francisco CA.

4. Remicade (infliximab) [package insert].2013.Janssen Biotech Inc Horsham PA.

5. Erbitux (cetuximab) [package insert].2004–2013.ImClone a wholly‐owned subsidiary of Eli Lilly and Company and Bristol‐Myers Squibb Company Branchburg NJ and Princeton NJ.

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Validation of an anti-α-Gal IgE fluoroenzyme-immunoassay for the screening of patients at risk of severe anaphylaxis to cetuximab;BMC Cancer;2023-01-09

2. A phase Ia dose-escalation trial of Ametumumab (a fully human monoclonal antibody against epidermal growth factor receptor) in patients with advanced solid malignancies;Therapeutic Advances in Medical Oncology;2023-01

3. Unambiguous identification of α-Gal epitopes in intact monoclonal antibodies by NMR spectroscopy;mAbs;2022-10-14

4. Anaphylaxis to Drugs, Biological Agents, and Vaccines;Immunology and Allergy Clinics of North America;2022-02

5. Recommandations pour la prescription et l’interprétation des examens biologiques utilisables dans le cadre du diagnostic ou du suivi des allergies, disponibles en France. Partie 4 : allergie aux médicaments;Revue Française d'Allergologie;2021-11